News
-
-
-
COMMUNIQUÉ DE PRESSE
Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven. Shield Therapeutics increasing physician awareness for ACCRUFeR® sales traction -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Hardman & Co Investor Forum Research on Windward (WNWD): High-growth maritime artificial intelligence play
Hardman & Co Investor Forum Research on Windward (WNWD): Explore the high-growth maritime artificial intelligence opportunities provided by Windward's AI-powered decision platform in the global maritime industry -